Samuel Ngai

Samuel Ngai is an experienced professional in the fields of Life Sciences, Biotechnology, Genomic Medicine, and Diagnostics. Samuel holds various advisory and leadership roles in companies such as Danaher Corporation, Portfolio Companies of Danaher Equity Ventures, TibaRay, Inc., SE3D, and Hummingbird Bioscience. Samuel also has a background in business development, corporate development, and management consulting with companies like Thermo Fisher Scientific, KLA, KT Venture Group, ZS Associates, and Mitchell Madison Group. Samuel holds a PhD and MS in Chemical Engineering from Massachusetts Institute of Technology and a BS in Chemical Engineering from the University of California, Berkeley.